This site is intended for healthcare professionals
News

New topline Tepezza data confirms its efficacy in longer disease duration, long-term durability and potential for retreatment in people living with thyroid eye disease (TED). Horizon Therapeutics

Read time: 3 mins
Last updated:3rd Aug 2020
Published:1st Aug 2020
Condition: Thyroid Eye Disease
Type: drug
Register free for full access to medthority.com